Form 8-K - Current report:
SEC Accession No. 0000950170-25-086142
Filing Date
2025-06-13
Accepted
2025-06-13 16:05:27
Documents
10
Period of Report
2025-06-12
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K fgen-20250612.htm   iXBRL 8-K 42692
  Complete submission text file 0000950170-25-086142.txt   147486

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fgen-20250612.xsd EX-101.SCH 24862
12 EXTRACTED XBRL INSTANCE DOCUMENT fgen-20250612_htm.xml XML 4696
Mailing Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133
Business Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 251046472
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)